MannKind CEO Michael PharmD's 2018 pay rises 13% to $1.5M
MannKind reports 2018 executive compensation
By ExecPay News
Published: April 10, 2020
MannKind reported fiscal year 2018 executive compensation information on April 10, 2020.
In 2018, six MannKind executives received on average a compensation package of $1.2M, a 33% increase compared to previous year.
Average pay of disclosed executives at MannKind
Michael E. Castagna, PharmD, Chief Executive Officer, received $1.5M in total, which increased by 13% compared to 2017. 55% of PharmD's compensation, or $833K, was in option awards. PharmD also received $20K in bonus, $150K in non-equity incentive plan, $500K in salary, as well as $5.7K in other compensation.
For fiscal year 2018, the median employee pay was $143,562 at MannKind. Therefore, the ratio of Michael E. Castagna, PharmD's pay to the median employee pay was 0 to one.
Michael E. Castagna, Chief Executive Officer, received a compensation package of $1.5M, which increased by 13% compared to previous year. 55% of the compensation package, or $833K, was in option awards.
David M. Kendall, Chief Medical Officer, earned $1.1M in 2018.
James P. McCauley, Jr, Chief Commercial Officer, received $1.1M in 2018.
David Thomson, General Counsel, earned $915K in 2018, a 12% increase compared to previous year.
Steven B. Binder, Chief Financial Officer, received $854K in 2018, which increases by 66% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 10, 2020.